Fullerton Fund Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Sell |
3,547
-4,750
| -57% | -$220K | 0.01% | 93 |
|
|
2025
Q1 | $506K | Buy |
+8,297
| New | +$506K | 0.03% | 82 |
|
|
2024
Q2 | – | Sell |
-9,408
| Closed | -$510K | – | 139 |
|
|
2024
Q1 | $510K | Buy |
+9,408
| New | +$510K | 0.02% | 71 |
|
|
2021
Q3 | – | Sell |
-3,538
| Closed | -$236K | – | 69 |
|
|
2021
Q2 | $236K | Buy |
+3,538
| New | +$236K | 0.02% | 76 |
|
|
2020
Q4 | – | Sell |
-3,180
| Closed | -$192K | – | 81 |
|
|
2020
Q3 | $192K | Buy |
+3,180
| New | +$192K | 0.03% | 58 |
|